Sort
23,748 grants matching “melanoma”
Multimeric Ligands for Targeting Melanoma
$636,070Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA
Melanocyte PDL1 control of UVB-induced IFN-I
$635,946Tyler J. Curiel · Dartmouth-Hitchcock Clinic · R01 · FY2024 · CA
Melanocyte PDL1 control of UVB-induced IFN-I
$635,946Tyler J. Curiel · Dartmouth-Hitchcock Clinic · R01 · FY2025 · CA
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer
$635,854Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
A Registry-Based Study of Patterns of Use of Targeted Therapies for Metastatic Cancers in Diverse Populations
$635,757Christine Veenstra · University Of Michigan At Ann Arbor · R37 · FY2023 · CA
Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology.
$635,587Nicole Franziska Steinmetz · University Of California, San Diego · U01 · FY2018 · CA
Impact of mutation burden on cancer growth and the immune landscape
$635,557Shridar Ganesan · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
Rational Approaches to Melanoma Therapy
$635,508Jessie Villanueva · Wistar Institute · U54 · FY2023 · CA
Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA
$635,296Douglas C Wallace · Children'S Hosp Of Philadelphia · R01 · FY2025 · CA
Validating and Characterizing a New Melanoma Therapeutic Target
$635,068Sara A Courtneidge · Oregon Health & Science University · R01 · FY2018 · CA
Yale Skin Diseases Research Core Center
$635,065Robert E. Tigelaar · Yale University · P30 · FY2008 · AR
Molecular Diagnostics Core Laboratory
$635,058Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Yale Skin Diseases Research Core Center
$635,034Robert E. Tigelaar · Yale University · P30 · FY2007 · AR
Cancer Genetics of Long Telomere Syndromes
$635,033Mary Y. Armanios · Johns Hopkins University · R01 · FY2025 · CA
Combating melanoma resistance by targeting ABL1/2
$634,772Rina Plattner · University Of Kentucky · R01 · FY2022 · CA
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
$634,715Elad Ziv · University Of California, San Francisco · R01 · FY2019 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$634,454Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2021 · CA
Regulatory T cells in cancer therapy
$634,434Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Regulatory T cells in cancer therapy
$634,296Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Gamma delta T cell based melanoma therapies
$634,246Xiaowei Xu · University Of Pennsylvania · R01 · FY2025 · CA
Optimizing TCR-CD3 signaling for immunotherapy of cancer
$634,208Michelle Krogsgaard · New York University School Of Medicine · R01 · FY2025 · CA
Immune dysregulation mechanisms of persistent post-COVID19 olfactory dysfunction
$634,157Lora Bankova · Brigham And Women'S Hospital · R01 · FY2025 · DC
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
$634,033Rebecca S Crowley · University Of Pittsburgh At Pittsburgh · U24 · FY2016 · CA
Redox imaging for breast cancer prognosis
$634,016Lin Z Li · University Of Pennsylvania · R01 · FY2017 · CA
Regulation of resistance to CDK4/6 inhibitor in breast cancer
$633,959Wenge Zhu · George Washington University · R01 · FY2025 · CA